HighMark Wealth Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

HighMark Wealth Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-124,966	Closed	-$2.18M	–	525
2020 Q4	$2.18M	Sell	124,966 -10,683	-8%	-$150K	1.88%	10
2020 Q3	$1.59M	Buy	135,649 +16,746	+14%	+$222K	1.43%	11
2020 Q2	$1.57M	Buy	118,903 +4,888	+4%	+$58.7K	1.73%	9
2020 Q1	$1.05M	Buy	114,015 +63,978	+128%	+$894K	1.27%	10
2019 Q4	$830K	Buy	+50,037	New	+$811K	0.89%	10

HighMark Wealth Management's OXFD Position: Q1 2021 in Review

HighMark Wealth Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 124,966 shares — an estimated $2.18M sold.

HighMark Wealth Management first reported a position in OXFD in Q4 2019 and held it in 5 quarters. The position peaked at $2.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

HighMark Wealth Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
HighMark Wealth Management sold 124,966 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $2.18M.
HighMark Wealth Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2019 and held it in 5 quarters.
HighMark Wealth Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.18M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on HighMark Wealth Management's 13F filing for Q1 2021, filed 22 Apr 2021.